Subscribe to RSS - Option Care

Option Care

Short takes: Wilpage, Option Care


Wilpage, a provider of home medical equipment in the New York metro area, has purchased Mediware’s CareTend software to boost its growing business.

Technology, need drive growth in enteral market


The enteral nutrition market is having a growth spurt, thanks to a combination of factors that show no signs of slowing down.

In brief: Industry stays busy, Margolis passes away


WASHINGTON – Although lawmakers are on recess, HME industry stakeholders have been holding strategy sessions on efforts to push through relief in non-bid areas.

Close monitoring of patients ensures outcomes, savings


ORLANDO, Fla. ­–­ Close monitoring of hemophilia patients ensures bleed rate stays low and the patients can be managed with less factor VIII, according to a study by Option Care being presented at the World Federation of Hemophilia 2016 World Congress meeting today.

In brief: CQRC asks CMS to slow down, Circadiance readies rebrand


WASHINGTON – The Council for Quality Respiratory Care says the findings of a recent Office of Inspector General report further demonstrate the need to slow down the national rollout of Medicare’s competitive bidding program.

Option Care awarded enteral contracts


BANNOCKBURN, Ill. – Option Care has accepted contracts in the Round 2 re-compete to provide enteral nutrition services across the country. The provider has participated in the competitive bidding program since 2011.

Study: Patient monitoring limits adverse drug effects


NEW ORLEANS – Close monitoring of patients receiving infusions of infliximab prevented adverse drug events, according to a new study from Option Care.

Outcomes prove value


SAN ANTONIO – Although it may seem like a no-brainer that patients who receive infusion therapy at home fare better—and at less cost—than other patients, providers need hard data to make their case to payers, says Paul Mastrapa.

Home infusion costs less, improves outcomes, according to Option Care study


SAN ANTONIO – Patients treated with immunoglobulin therapy at home with a high level of clinical oversight by Option Care had better outcomes than others receiving the therapy, according to a recent s

Reporter's notebook: Healthcare reform drives growth


Mention the Affordable Care Act to a roomful of HME providers and you’re likely to hear groans about higher costs for their businesses. Home infusion provider Paul Mastrapa, however, sees it as a growth driver.